Cuál es el precio por PaxMedica, Inc. Common Stock (PXMD)

Precio por PaxMedica, Inc. Common Stock (PXMD) es de$0.0005

Cuál es la capitalización de mercado por PaxMedica, Inc. Common Stock (PXMD)

Capitalización de mercado por PaxMedica, Inc. Common Stock (PXMD) es $63.13K

PaxMedica, Inc. Common Stock (PXMD) Historial de Precios

PaxMedica, Inc. is a biopharmaceutical company currently in the clinical development phase, dedicated to advancing anti-purinergic drug therapies (APTs). These innovative treatments are specifically designed to address complex neurological disorders presenting with stubborn and persistent symptoms. The company's primary investigative drug is PAX-101, an intravenous (IV) form of suramin, which is being explored for a variety of conditions. These include autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, post-COVID-19 syndrome (commonly known as "long COVID"), and human African trypanosomiasis. Furthermore, PaxMedica is also developing PAX-102, an intranasal version of suramin, intended for various neurological applications. The company, which was incorporated in 2018 and has its headquarters in Tarrytown, New York, previously operated as Purinix Pharmaceuticals LLC before rebranding to PaxMedica, Inc. in April 2020. It functions as a subsidiary of Tardimed Sciences LLC.

Año	Rendimiento
2026 (TTM)	0.00%
2025	-99.67%
2024	-90.14%
2023	-97.74%
2022	0.00%

Año

Rendimiento

2026 (TTM)

0.00%

2025

-99.67%

2024

-90.14%

2023

-97.74%

2022

0.00%

Empresa	Precio de la acción	Cambio 1a%	País
Vertex Pharmaceuticals Incorporated VRTX.US	$522.59	31.99%	US
Argenx SE ARGX.US	$863.65	33.57%	NL
Lonza Group AG LONN.SW	$744.96	8.94%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.08K	-6.68%	KR
UCB S.A. UCB.BR	$259.89	16.65%	BE

Empresa

Precio de la acción

Cambio 1a%

País